Angiogenese og lungekreft - utenlandsopphold Oxford
- Prosjektnummer
- SFP986-11
- Ansvarlig person
- Tom Dønnem
- Institusjon
- Universitetssykehuset Nord-Norge HF
- Prosjektkategori
- Korttidsprosjekt (inkludert små driftsmidler)
- Helsekategori
- Cancer and neoplasms
- Forskningsaktivitet
- 1. Underpinning
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas.
BMC Clin Pathol 2012;12():5. Epub 2012 feb 29
PMID: 22375962
Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas.
BMC Clin Pathol 2012;12():7. Epub 2012 mai 3
PMID: 22554285
High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator.
Oncoimmunology 2012 Jan;1(1):75-77.
PMID: 22720216
Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas.
PLoS One 2012;7(10):e47068. Epub 2012 okt 5
PMID: 23071715
Prognostic impacts of hypoxic markers in soft tissue sarcoma.
Sarcoma 2012;2012():541650. Epub 2012 feb 20
PMID: 22454562
[Mutation testing for non-small-cell lung cancer].
Tidsskr Nor Laegeforen 2012 Apr;132(8):952-5.
PMID: 22562326
In NSCLC, VEGF-A response to hypoxia may differ between squamous cell and adenocarcinoma histology.
Anticancer Res 2012 Nov;32(11):4729-36.
PMID: 23155236
Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome.
Lung Cancer 2012 Feb;75(2):235-41. Epub 2011 jul 18
PMID: 21764478
MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer.
PLoS One 2012;7(1):e29671. Epub 2012 jan 25
PMID: 22295063
Gene expression assays as prognostic and predictive markers in early stage non-small cell lung cancer.
J Thorac Dis 2012 Apr;4(2):212-3.
PMID: 22833829
Bridging the distance: a prospective tele-oncology study in Northern Norway.
Support Care Cancer 2011 Nov. Epub 2011 nov 11
PMID: 22076621
The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas.
J Transl Med 2011;9():200. Epub 2011 nov 22
PMID: 22107784
The prognostic impact of TGF-ß1, fascin, NF-?B and PKC-? expression in soft tissue sarcomas.
PLoS One 2011;6(3):e17507. Epub 2011 mar 3
PMID: 21390241
Prognostic impact of lymphocytes in soft tissue sarcomas.
PLoS One 2011;6(1):e14611. Epub 2011 jan 27
PMID: 21298041
Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas.
Int J Oncol 2011 Apr;38(4):1031-40. Epub 2011 jan 24
PMID: 21271213
Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Lung Cancer 2011 Jun;72(3):294-302. Epub 2010 nov 13
PMID: 21075472
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.
J Transl Med 2011;9():104. Epub 2011 jul 6
PMID: 21733164
The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer.
J Thorac Oncol 2011 Apr;6(4):824-33.
PMID: 21173711
Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2.
PLoS One 2011;6(5):e19773. Epub 2011 mai 16
PMID: 21603628
Correlation and coexpression of HIFs and NOTCH markers in NSCLC.
Anticancer Res 2011 May;31(5):1603-6.
PMID: 21617216
Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival.
PLoS One 2011;6(8):e23847. Epub 2011 aug 22
PMID: 21887331
The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer.
J Thorac Oncol 2011 Jan;6(1):209-17.
PMID: 21107292
Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor size.
Clin Lung Cancer 2011 Mar;12(2):106-15. Epub 2011 apr 11
PMID: 21550557
Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization.
J Transl Med 2011;9():6. Epub 2011 jan 10
PMID: 21219656
Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival.
Cancer 2011 Jul;117(14):3193-200. Epub 2011 jan 24
PMID: 21264844
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport, Helse Nord